SEC Form 4 · accession 0001209191-18-000869
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John C Thomas
Director
Period of report
Jan 2, 2018
Accepted (ET)
Jan 3, 2018 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2018 | G | 4,500 | $0.00 | D | 274,155 | D |
Table II — derivative securities
No Table II lines on this filing.